Cannabis And The FDA – Establishing A Compliant Hemp Business, A Legal Limbo For Hemp Products

Product Id : FDA325
Instructor : Rachael Z. Ardanuy, Esq.
Oct 07, 2020 1:00 PM ET | 12:00 PM CT | 10:00 AM PT | 60 Minutes

Download Conference Material

Download Here (Password Needed)

Description

This webinar with regulatory compliance expert and Cannabis Business Attorney Rachael Z. Ardanuy, Esq. will discuss the current status of cannabinoids as medical products in the United States. The focus will be on what we can learn from the FDA approval of Epidolex (Cannabidiol) oral solution 100 mg/mL. You will be provided guidance on how to obtain research information and understand the current market for Cannabidiol (CBD) in the U.S. 

This webinar will explore current FDA-approved natural and synthetic cannabinoids and the treatments they purport to provide. Cannabinoids are a hot topic in the current pharmaceutical industry.  Knowledge of the current FDA approvals and research being reported will assist in predicting the future of this class of compounds and deciding whether a given firm wants to be part of it.

Why you should attend : 

  • Audience will gain clarity on the historical and current legal status of hemp and hemp derived products at the federal level.
  • Audience will understand the various laws that impact the hemp and hemp derived precuts industry
  • Audience will learn the evolution of the legal status of hemp and hemp derived products, and where we believe that status will go in the future.

Scope of Webinar : 

  • Provide history of hemp’s legal status in US
  • Explain 2018 Farm Bill’s impact on hemp cultivation
  • Discuss hurdles regarding FDA’s treatment of hemp derived products
  • Provide current status of regulations proposed by FDA
  • Market trends, expectations and experiences I’ve seen with clients

Who Will Benefit

  • Hemp/nutraceutical entrepreneur
  • medical practitioners
  • advocates for alternative medicine
  • Pharmaceutical executives
  • Research and development professionals in pharmaceutical companies
  • Regulatory affairs personnel in pharmaceutical companies
  • Food Executive
  • Quality Professionals
  • Regulatory Compliance Officer
Speaker Profile:

Rachael Z. Ardanuy, Esq., is a Denver-based Cannabis Business Attorney licensed in Colorado and Florida. Since relocating from Florida to Colorado in 2015, Rachael has dedicated her career to advising, educating and advocating for entrepreneurs, business owners, investors, patients and anyone else connected to the commercial hemp and marijuana (cannabis) industries. Using her knowledge of hemp and marijuana laws and regulations, Rachael also provides value to her clients by advising on and preparing estate plans that meet the unique needs of her clients, whose involvement in the marijuana industry present novel issues for estate and succession planning. Rachael’s extensive knowledge of the applicable laws, regulations, licensing processes, cannabis business transactions and best practices give her clients a leg up and serve to normalize the cannabis industry as a whole.


Available Options